Version 2.0 of the study will add bunny scent to the stuffed rabbits if motion and heat aren’t enough to fool the pythons in Florida.

PyApp seems to be taking the Python world by storm, providing long-awaited click-and-run Python distribution. For developers ...

They look, move and even smell like the kind of furry Everglades marsh rabbit a Burmese python would love to eat.

In July 2025, Recursion Pharmaceuticals, Inc. (NASDAQ:RXRX) expanded its rare disease pipeline by acquiring REV102, an oral ENPP1 inhibitor for hypophosphatasia (HPP), a disorder with no existing oral ...

It offered multiple conflicting reasons for its absence, some of which were controversial enough that NBC reporters wrote ...

When something goes wrong with an AI assistant, our instinct is to ask it directly: "What happened?" or "Why did you do that?

Clinical-stage biotech Recursion Pharmaceuticals ' (NASDAQ: RXRX) stock took it on the chin in the first trading day of the week. Monday saw investors back out of the company's shares, leaving ...

Recursion's AI-designed cancer drugs REC-3565 and REC-617 show early clinical promise, with one patient responding unexpectedly well to treatment.

Ray further emphasized that REC-3565, currently in Phase 1 trials and developed using Recursion’s advanced AI platform, would not have been conceived through traditional human design methods.

Shares of Recursion Pharmaceuticals (NASDAQ: RXRX) fell this week. The stock lost 24% as of market close on Friday. The move comes as the S&P 500 and Nasdaq Composite both slipped slightly ...